152 related articles for article (PubMed ID: 38492358)
1. Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.
Abdelmaksoud NM; Al-Noshokaty TM; Abdelhamid R; Abdellatif N; Mansour A; Mohamed R; Mohamed AH; Khalil NAE; Abdelhamid SS; Mohsen A; Abdelaal H; Tawfik A; Elshaer SS
Pathol Res Pract; 2024 Apr; 256():155237. PubMed ID: 38492358
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
Dewanjee S; Bhattacharjee N
Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
[TBL] [Abstract][Full Text] [Related]
6. [The Role of TGF-β1/SMAD in Diabetic Nephropathy: Mechanisms and Research Development].
Wang Y; Guo J; Shao B; Chen H; Lan H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1065-1073. PubMed ID: 38162063
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
9. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
10. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
[TBL] [Abstract][Full Text] [Related]
11. The regulatory role of miRNA and lncRNA on autophagy in diabetic nephropathy.
Yu S; Li Y; Lu X; Han Z; Li C; Yuan X; Guo D
Cell Signal; 2024 Jun; 118():111144. PubMed ID: 38493883
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
Kato M; Natarajan R
Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
[TBL] [Abstract][Full Text] [Related]
14. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
Wang L; Wang HL; Liu TT; Lan HY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.
Kato M; Natarajan R
Semin Nephrol; 2012 May; 32(3):253-60. PubMed ID: 22835456
[TBL] [Abstract][Full Text] [Related]
16. Construction of a TF-miRNA-mRNA Regulatory Network for Diabetic Nephropathy.
Dong F; Zheng L; Yang G
Arch Esp Urol; 2024 Jan; 77(1):104-112. PubMed ID: 38374020
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
Peng L; Chen Y; Shi S; Wen H
Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
[TBL] [Abstract][Full Text] [Related]
18. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
Ming J; Sana SRGL; Deng X
Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
[TBL] [Abstract][Full Text] [Related]
19. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
[TBL] [Abstract][Full Text] [Related]
20. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
